Skip to main content
Kanti Rai, MD, Oncology, New Hyde Park, NY

Kanti Rai MD


Professor of Medicine, Albert Einstein College of Medicine

Join to View Full Profile
  • LIJMC Dept of Med Hematology Oncology Chief270 05 76TH AvenueNew Hyde Park, NY 11040

  • Phone+1 718-470-7135

  • Fax+1 718-470-4250

Dr. Rai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • North Shore University Hospital - Northwell Health
    North Shore University Hospital - Northwell HealthResidency, Occupational Medicine, 1960 - 1960
  • Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical Center
    Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 1958 - 1959
  • Lincoln Medical and Mental Health Center
    Lincoln Medical and Mental Health CenterInternship, Transitional Year, 1957 - 1958
  • Sawai Man Singh Medical College
    Sawai Man Singh Medical CollegeClass of 1955

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1968 - 2026
  • Pediatrics
    American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • Newsday - Top Doctors on Long Island Castle Connolly, 2008, 2010-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Gene Expression and Cytokine Analyses Identify Markers of Progression from CLL-like Monoclonal B-Cell Lymphocytosis to Chronic Lymphocytic Leukemia
    Kanti R Rai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • CLL B Cells Develop Resistance to Ibrutinib By Reinvigorating the IL-4R - IL-4 Axis Blocked By BrutonÍs Tyrosine Kinase Inhibitors Including Acalabrutinib and Zanubrut...
    Kanti R Rai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Deciphering the CXCL9-CXCL10-CXCL11/CXCR3 Axis in CLL-like Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia: A New Target for Immune Activation?
    Kanti R Rai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Ibrutinib Treatment Reduces Myeloid Derived Suppressor Cell Numbers and Function in Chronic Lymphocytic Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • CLL Intraclonal Fractions Defined By Time Since Cell Birth/Division Promote a Leukemia-Supportive, Immune-Tolerant Microenvironment By Distinct Mechanisms 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Extended Survival in CLL Patients Who Discontinued Idelalisib Because of Colitis Correlates with Higher Th17 Levels in Blood and Colon Tissue 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Press Mentions

  • Drug Duo May Be a Weapon Against a Common Leukemia
    Drug Duo May Be a Weapon Against a Common LeukemiaAugust 11th, 2019
  • Lymphoma Research Foundation's 2019 Swirl: Chicago Raises More Than $130,000
    Lymphoma Research Foundation's 2019 Swirl: Chicago Raises More Than $130,000June 5th, 2019
  • Management of Older Patients with Chronic Lymphocytic Leukemia
    Management of Older Patients with Chronic Lymphocytic LeukemiaDecember 10th, 2017
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: